• GENFIT Announces Launch of Proposed Global Offering and Nasdaq Listing firstwordpharma
    March 15, 2019
    GENFIT intends to grant the underwriters for the offering (the "Underwriters") a 30-day option to purchase additional ADSs and/or ordinary shares in an aggregate amount of up to 15% of the total number of ADSs and ordinary shares proposed to be sold in th
PharmaSources Customer Service